The Mainstream Patient: January 3, 2023
This week's edition of the Mainstream Patient features stories about dry shampoos that don't contain benzene, the best ferulic acid serums, Hijabi hair care, and more.
What to Look Forward to in 2023
The Dermatology Times® Editorial Advisory Board members share what they hope to see in 2023.
The Weekly Roundup: December 26-30
ICYMI, this week we had stories about the top 5 articles of 2022, adjuvant treatment for Merkel cell carcinoma, favorite skin care products of 2022, and more.
Trending Skin Care Products of 2022
Dermatology Times® features a roundup of trending skin care products each month. Find out what products we enjoyed the most from 2022.
What’s Trending in Skin Care: December 2022
Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are trending for the month of December.
2022 in Review: Benzene Contamination
A look back at benzene found in personal care products throughout the year and how companies have responded.
Q&A: Muneeb Shah, DO, Discusses What it Means to Have Healthy Skin
Dermatology Times® spoke with Shah in November on how he uses his social media platform to fight healthy skin misinformation.
Top 5 Articles of 2022
As 2022 comes to a close, take a look at the top 5 articles from the year.
The Weekly Roundup: December 19-23
ICYMI, this week we had stories about roflumilast cream for plaque psoriasis, a conversation about JAK inhibitors for atopic dermatitis, mental health related to vitiligo, and more.
A Conversation About JAK Inhibitors in Atopic Dermatitis
In this DermView series recap, Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, review the changing landscape of atopic dermatitis treatment options and what is on the horizon.
SNDA Submitted for Roflumilast Cream for the Treatment of Plaque Psoriasis Down to 2 Years
Arcutis Biotherapeutics' indication expansion is based on data from MUSE studies.
The Weekly Roundup: December 12-16
ICYMI, this week we had stories about holistic treatment for atopic dermatitis management, a recap of the 2022 Revolutionizing Atopic Dermatitis Conference, unmet needs in acne management, and more.
Recap of the 2022 RAD Conference
Catch up on coverage from the 2022 Revolutionizing Atopic Dermatitis Conference.
The Cutaneous Connection: JAK Inhibitor Safety for Treating AD
In this episode, Christopher Bunick, MD, PhD, discusses a paper he recently co-authored, which explores JAK inhibitor safety compared to traditional systemic therapies for atopic dermatitis.
Hydrinity Accelerated Skin Science Launches New Skin Care Line
Hyaluronic acid is the superhero ingredient of this new skin care line.
Updates on Topical Therapy Treatment for AD
Jonathan Silverberg, MD, PhD, MPHS, gives an overview of topical therapies for atopic dermatitis at the 2022 virtual RAD conference.
How to Support Caregivers of Children with AD
A 2022 RAD Conference poster presentation explored how to better support caregivers of children with atopic dermatitis.
Racial Differences of AD Characteristics in US Patients
A poster presentation from the 2022 RAD Conference analyzed manifestations of atopic dermatitis across racial groups.
What to Expect at the 2022 Virtual RAD Conference
The Revolutionizing Atopic Dermatitis Conference takes place on December 11th, 2022.
The Weekly Roundup: December 5-9
ICYMI, this week we had stories about the upcoming 2023 South Beach Symposium Meeting, acetic acid for wound healing, CBD for acne treatment, and more.
Endo Aesthetics Cancels Production and Sale of Collagenase Clostridium Histolyticum-Aaes Injection
Cancellation is due to concerns about the extent of bruising following initial treatment and prolonged skin discoloration.
The Mainstream Patient: December 5
This week's edition of the Mainstream Patient features stories about the 13th International Facial Plastic Surgery Symposium, skin barrier advice, rosemary oil for hair growth, and more.
Limited Options for Pediatric Psoriasis Treatment
Recent review explores the difficulties of treating pediatric psoriasis.
The Weekly Roundup: November 28 - December 2
ICYMI, this week we had stories about characteristics of generalized pustular psoriasis, the psychosocial impact of vitiligo, new laser treatments for acne, and more.
Connection Between Psoriasis and Depression
New research examined brain structure and connectivity in patients with psoriasis.
What’s Trending in Skin Care: November 2022
Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are trending for the month of November.
FDA Clears Accure Laser System for Acne Treatment
Accure’s system is the first 1726nm-based laser device with both FDA and CE Mark clearances.
Editorial Advisory Board Members and Editors Share What They’re Thankful For
Happy Thanksgiving from the Dermatology Times® Editorial Advisory Board and editors!
Recap from the Society of Dermatology Physician Assistants Conference
Catch up on coverage from the 2022 Society of Dermatology Physician Assistants Conference.
BPDCN and Leukemia: What’s the Difference?
Blastic plasmacytoid dendritic neoplasm is commonly misdiagnosed as various forms of leukemia.
2 Clarke Drive Cranbury, NJ 08512